Investmark Advisory Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,444
Closed -$228K 101
2022
Q4
$228K Buy
2,444
+347
+17% +$33.5K 0.17% 90
2022
Q3
$200K Buy
+2,097
New +$208K 0.18% 93
2022
Q1
Sell
-307
Closed -$31K 141
2021
Q4
$31K Buy
+307
New +$28.4K 0.03% 186

Other funds holding CVS

Investmark Advisory Group's CVS Position: Q1 2023 in Review

Investmark Advisory Group sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,444 shares — an estimated $228K sold.

Investmark Advisory Group first reported a position in CVS in Q4 2021 and held it in 3 quarters. The position peaked at $228K in Q4 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Investmark Advisory Group reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Investmark Advisory Group sold 2,444 CVS Health shares in Q1 2023, an estimated $228K.
  • Investmark Advisory Group first reported a position in CVS Health in Q4 2021 and held it in 3 quarters.
  • Investmark Advisory Group's CVS Health position peaked at $228K in Q4 2022.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Investmark Advisory Group's 13F filing for Q1 2023, filed 16 May 2023.